{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:11:37Z","timestamp":1794892297192,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15128-2","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T11:33:36Z","timestamp":1762947216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The clinical value of predicting lymphovascular invasion in patients with invasive lung adenocarcinoma based on the intratumoral and peritumoral CT radiomics models"],"prefix":"10.1186","volume":"25","author":[{"given":"Miaomiao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"3","key":"15128_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"15128_CR2","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"15128_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000488859","volume":"95","author":"SY Sung","year":"2018","unstructured":"Sung SY, Kwak YK, Lee SW, Jo IY, Park JK, Kim KS, et al. Lymphovascular invasion increases the risk of nodal and distant recurrence in node-negative stage I-IIA non-small-cell lung cancer. Oncology. 2018;95(3):156\u201362.","journal-title":"Oncology"},{"key":"15128_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.lungcan.2020.04.033","volume":"146","author":"JK Yun","year":"2020","unstructured":"Yun JK, Lee GD, Choi S, Kim HR, Kim YH, Kim DK, et al. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: a propensity score-matched analysis. Lung Cancer. 2020;146:105\u201311.","journal-title":"Lung Cancer"},{"issue":"9","key":"15128_CR5","first-page":"1045","volume":"52","author":"H Yang","year":"2022","unstructured":"Yang H, Mei T. Prognostic significance of visceral pleural invasion in patients with surgically resected small-cell lung cancer: a population-based study. Jpn J Clin Oncol. 2022;52(9):1045\u201355.","journal-title":"Jpn J Clin Oncol"},{"key":"15128_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.lungcan.2021.08.017","volume":"161","author":"A De Giglio","year":"2021","unstructured":"De Giglio A, Di Federico A, Gelsomino F, Ardizzoni A. Prognostic relevance of pleural invasion for resected NSCLC patients undergoing adjuvant treatments: a propensity score-matched analysis of SEER database. Lung Cancer. 2021;161:18\u201325.","journal-title":"Lung Cancer"},{"issue":"11","key":"15128_CR7","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1001\/jamaoncol.2020.4232","volume":"6","author":"R Pathak","year":"2020","unstructured":"Pathak R, Goldberg SB, Canavan M, Herrin J, Hoag JR, Salazar MC, et al. Association of survival with adjuvant chemotherapy among patients with early-stage non-small cell lung cancer with vs without high-risk clinicopathologic features. JAMA Oncol. 2020;6(11):1741\u201350.","journal-title":"JAMA Oncol"},{"key":"15128_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109111","volume":"129","author":"G Yang","year":"2020","unstructured":"Yang G, Nie P, Zhao L, Guo J, Xue W, Yan L, et al. 2D and 3D texture analysis to predict lymphovascular invasion in lung adenocarcinoma. Eur J Radiol. 2020;129:109111.","journal-title":"Eur J Radiol"},{"issue":"17","key":"15128_CR9","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1111\/1759-7714.14530","volume":"13","author":"JS Cai","year":"2022","unstructured":"Cai JS, Wang X, Yang F, Li Y, Qiu MT. Lymphovascular invasion: a non-sized T descriptor for stage IA non-small cell lung cancer. Thorac Cancer. 2022;13(17):2413\u201320.","journal-title":"Thorac Cancer"},{"key":"15128_CR10","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2021.20385","volume":"151","author":"LC Guglielmetti","year":"2021","unstructured":"Guglielmetti LC, Schneiter D, Hillinger S, Opitz I, Caviezel C, Weder W, et al. Lymphovascular invasion is an independent prognostic factor for survival in pathologically proven N2 non-small cell lung cancer. Swiss Med Wkly. 2021;151:w20385.","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"15128_CR11","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1016\/j.cllc.2022.12.006","volume":"24","author":"L Suaiti","year":"2023","unstructured":"Suaiti L, Sullivan TB, Rieger-Christ KM, Servais EL, Suzuki K, Burks EJ. Vascular invasion predicts recurrence in stage IA2-IB lung adenocarcinoma but not squamous cell carcinoma. Clin Lung Cancer. 2023;24(3):e126\u201333.","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"15128_CR12","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1186\/s12885-020-07691-7","volume":"20","author":"T Tsuchiya","year":"2020","unstructured":"Tsuchiya T, Kamohara R, Muraoka M, Nagayasu T, Saeki S, Takenoyama M, et al. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study. BMC Cancer. 2020;20(1):1192.","journal-title":"BMC Cancer"},{"issue":"1","key":"15128_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.21037\/tlcr-24-820","volume":"14","author":"T Watanabe","year":"2025","unstructured":"Watanabe T, Tanahashi M, Suzuki E, Yoshii N, Kohama T, Iguchi K, et al. Efficacy of adjuvant tegafur-uracil (UFT) in early-stage non-small cell lung cancer with poor prognostic factors. Transl Lung Cancer Res. 2025;14(1):139\u201349.","journal-title":"Transl Lung Cancer Res"},{"key":"15128_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.lungcan.2022.07.016","volume":"171","author":"I Yambayev","year":"2022","unstructured":"Yambayev I, Sullivan TB, Rieger-Christ KM, Servais EL, Stock CT, Quadri SM, et al. Vascular invasion identifies the most aggressive histologic subset of stage I lung adenocarcinoma: implications for adjuvant therapy. Lung Cancer. 2022;171:82\u20139.","journal-title":"Lung Cancer"},{"key":"15128_CR15","unstructured":"Board PDQATE. Non-small cell lung cancer treatment (PDQ\u00ae): Health Professional Version. InPDQ Cancer Information Summaries. edn. Bethesda (MD): National Cancer Institute (US); 2002."},{"issue":"4","key":"15128_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2214\/AJR.21.25618","volume":"217","author":"J Choe","year":"2021","unstructured":"Choe J, Kim MY, Yun JK, Lee GD, Kim YH, Choi S, et al. Sublobar resection in stage IA non-small cell lung cancer: role of preoperative CT features in predicting pathologic lymphovascular invasion and postoperative recurrence. AJR Am J Roentgenol. 2021;217(4):871\u201381.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"15128_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15147","volume":"9","author":"Z Zuo","year":"2023","unstructured":"Zuo Z, Fan X, Tang Y, Zhang Y, Peng X, Zeng W, et al. Deep learning-powered 3D segmentation derives factors associated with lymphovascular invasion and prognosis in clinical T1 stage non-small cell lung cancer. Heliyon. 2023;9(4):e15147.","journal-title":"Heliyon"},{"issue":"1","key":"15128_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13058-022-01516-0","volume":"24","author":"X Wang","year":"2022","unstructured":"Wang X, Xie T, Luo J, Zhou Z, Yu X, Guo X. Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment. Breast Cancer Res. 2022;24(1):20.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"15128_CR19","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00330-022-09055-0","volume":"33","author":"J Li","year":"2023","unstructured":"Li J, Qiu Z, Zhang C, Chen S, Wang M, Meng Q, et al. ITHscore: comprehensive quantification of intra-tumor heterogeneity in NSCLC by multi-scale radiomic features. Eur Radiol. 2023;33(2):893\u2013903.","journal-title":"Eur Radiol"},{"issue":"20","key":"15128_CR20","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3748\/wjg.v28.i20.2176","volume":"28","author":"K Lv","year":"2022","unstructured":"Lv K, Cao X, Du P, Fu JY, Geng DY, Zhang J. Radiomics for the detection of microvascular invasion in hepatocellular carcinoma. World J Gastroenterol. 2022;28(20):2176\u201383.","journal-title":"World J Gastroenterol"},{"key":"15128_CR21","doi-asserted-by":"publisher","unstructured":"Ventura D, Schindler P, Masthoff M, G\u00f6rlich D, Dittmann M, Heindel W, et al. Radiomics of tumor heterogeneity in (18)F-FDG-PET-CT for predicting response to immune checkpoint inhibition in therapy-na\u00efve patients with advanced non-small-cell lung cancer. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15082297.","DOI":"10.3390\/cancers15082297"},{"issue":"3","key":"15128_CR22","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00330-022-09174-8","volume":"33","author":"L Wu","year":"2023","unstructured":"Wu L, Lou X, Kong N, Xu M, Gao C. Can quantitative peritumoral CT radiomics features predict the prognosis of patients with non-small cell lung cancer? A systematic review. Eur Radiol. 2023;33(3):2105\u201317.","journal-title":"Eur Radiol"},{"key":"15128_CR23","doi-asserted-by":"publisher","first-page":"1185808","DOI":"10.3389\/fonc.2023.1185808","volume":"13","author":"J Wang","year":"2023","unstructured":"Wang J, Zheng Z, Zhang Y, Tan W, Li J, Xing L, et al. (18)F-fdg pet\/ct radiomics for prediction of lymphovascular invasion in patients with early stage non-small cell lung cancer. Front Oncol. 2023;13:1185808.","journal-title":"Front Oncol"},{"issue":"1","key":"15128_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00259-020-04747-5","volume":"48","author":"P Nie","year":"2021","unstructured":"Nie P, Yang G, Wang N, Yan L, Miao W, Duan Y, et al. Additional value of metabolic parameters to PET\/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma. Eur J Nucl Med Mol Imaging. 2021;48(1):217\u201330.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"15128_CR25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1148\/radiol.10090924","volume":"256","author":"L Zhang","year":"2010","unstructured":"Zhang L, Yankelevitz DF, Henschke CI, Jirapatnakul AC, Reeves AP, Carter D. Zone of transition: a potential source of error in tumor volume estimation. Radiology. 2010;256(2):633\u20139.","journal-title":"Radiology"},{"issue":"4","key":"15128_CR26","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ctrv.2013.10.001","volume":"40","author":"SL Wood","year":"2014","unstructured":"Wood SL, Pernemalm M, Crosbie PA, Whetton AD. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. Cancer Treat Rev. 2014;40(4):558\u201366.","journal-title":"Cancer Treat Rev"},{"key":"15128_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114681","volume":"156","author":"T Luo","year":"2025","unstructured":"Luo T, Guo J, Xi J, Luo X, Fu Z, Chen W, et al. Development and validation of a CT-based radiomics machine learning model for differentiating immune-related interstitial pneumonia. Int Immunopharmacol. 2025;156:114681.","journal-title":"Int Immunopharmacol"},{"issue":"21","key":"15128_CR28","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res. 2017;77(21):e104\u20137.","journal-title":"Cancer Res"},{"issue":"4","key":"15128_CR29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/labmed\/lmac122","volume":"54","author":"H Bi","year":"2023","unstructured":"Bi H, Yin L, Fang W, Song S, Wu S, Shen J. Association of CEA, NSE, CYFRA 21\u20131, SCC-Ag, and ProGRP with clinicopathological characteristics and chemotherapeutic outcomes of lung cancer. Lab Med. 2023;54(4):372\u20139.","journal-title":"Lab Med"},{"issue":"2","key":"15128_CR30","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1080\/02648725.2023.2166708","volume":"39","author":"L Ren","year":"2023","unstructured":"Ren L, Yang Y. Value of dual-source CT dual-energy parameters combined with serum detection of VEGF and CEA in the diagnosis of early lung cancer. Biotechnol Genet Eng Rev. 2023;39(2):1000\u201311.","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"7","key":"15128_CR31","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1111\/1759-7714.13449","volume":"11","author":"C de Jong","year":"2020","unstructured":"de Jong C, Deneer VHM, Kelder JC, Ruven H, Egberts TCG, Herder GJM. Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Thorac Cancer. 2020;11(7):1790\u2013800.","journal-title":"Thorac Cancer"},{"issue":"6","key":"15128_CR32","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2214\/AJR.21.25814","volume":"217","author":"C Li","year":"2021","unstructured":"Li C, Tian Y, Shen Y, Wen B, He Y. Utility of volumetric metabolic parameters on preoperative FDG PET\/CT for predicting tumor lymphovascular invasion in non-small cell lung cancer. AJR Am J Roentgenol. 2021;217(6):1433\u201343.","journal-title":"AJR Am J Roentgenol"},{"key":"15128_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7521987","volume":"2017","author":"JH Lee","year":"2017","unstructured":"Lee JH, Lee SW. The roles of carcinoembryonic antigen in liver metastasis and therapeutic approaches. Gastroenterol Res Pract. 2017;2017:7521987.","journal-title":"Gastroenterol Res Pract"},{"issue":"3 Suppl 8","key":"15128_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0093-7754(03)00233-1","volume":"30","author":"J Marshall","year":"2003","unstructured":"Marshall J. Carcinoembryonic antigen-based vaccines. Semin Oncol. 2003;30(3 Suppl 8):30\u20136.","journal-title":"Semin Oncol"},{"issue":"3","key":"15128_CR35","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1378\/chest.15-0559","volume":"149","author":"Y Shimada","year":"2016","unstructured":"Shimada Y, Saji H, Kato Y, Kudo Y, Maeda J, Yoshida K, et al. The frequency and prognostic impact of pathological microscopic vascular invasion according to tumor size in non-small cell lung cancer. Chest. 2016;149(3):775\u201385.","journal-title":"Chest"},{"issue":"39","key":"15128_CR36","doi-asserted-by":"publisher","first-page":"8203","DOI":"10.2174\/0929867328666210720143721","volume":"28","author":"S Dallavalasa","year":"2021","unstructured":"Dallavalasa S, Beeraka NM, Basavaraju CG, Tulimilli SV, Sadhu SP, Rajesh K, et al. The role of tumor associated macrophages (TAMs) in cancer progression, chemoresistance, angiogenesis and metastasis - current status. Curr Med Chem. 2021;28(39):8203\u201336.","journal-title":"Curr Med Chem"},{"issue":"12","key":"15128_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113507","volume":"42","author":"K Banerjee","year":"2023","unstructured":"Banerjee K, Kerzel T, Bekkhus T, de Souza Ferreira S, Wallmann T, Wallerius M, et al. VEGF-C-expressing TAMs rewire the metastatic fate of breast cancer cells. Cell Rep. 2023;42(12):113507.","journal-title":"Cell Rep"},{"issue":"2","key":"15128_CR38","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00330-022-09109-3","volume":"33","author":"Q Chen","year":"2023","unstructured":"Chen Q, Shao J, Xue T, Peng H, Li M, Duan S, et al. Intratumoral and peritumoral radiomics nomograms for the preoperative prediction of lymphovascular invasion and overall survival in non-small cell lung cancer. Eur Radiol. 2023;33(2):947\u201358.","journal-title":"Eur Radiol"},{"issue":"3","key":"15128_CR39","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1109\/JBHI.2020.3002805","volume":"25","author":"L Meng","year":"2021","unstructured":"Meng L, Dong D, Chen X, Fang M, Wang R, Li J, et al. 2D and 3D CT radiomic features performance comparison in characterization of gastric cancer: a multi-center study. IEEE J Biomed Health Inform. 2021;25(3):755\u201363.","journal-title":"IEEE J Biomed Health Inform"},{"issue":"1","key":"15128_CR40","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1186\/s12885-021-08899-x","volume":"21","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Yao W, Xu BC, Lei YY, Guo QK, Liu LZ, et al. Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive radiomic biomarkers. BMC Cancer. 2021;21(1):1167.","journal-title":"BMC Cancer"},{"issue":"9","key":"15128_CR41","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s11547-023-01676-9","volume":"128","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang G, Qiu X, Yin J, Tan W, Yin X, et al. Radiomics under 2D regions, 3D regions, and peritumoral regions reveal tumor heterogeneity in non-small cell lung cancer: a multicenter study. Radiol Med. 2023;128(9):1079\u201392.","journal-title":"Radiol Med"},{"issue":"7","key":"15128_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.70058","volume":"16","author":"M Kim","year":"2025","unstructured":"Kim M, Park GS, Lee KY, Moon SW, Sung YE. Role of TP53 mutations and EGFR amplification in risk stratification of early-stage EGFR-mutated non-small cell lung cancer with immunohistochemistry as a surrogate marker. Thorac Cancer. 2025;16(7):e70058.","journal-title":"Thorac Cancer"},{"issue":"9","key":"15128_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100245","volume":"36","author":"K Argyropoulos","year":"2023","unstructured":"Argyropoulos K, Basu A, Park K, Zhou F, Moreira AL, Narula N. Correlation of programmed death-ligand 1 expression with lung adenocarcinoma histologic and molecular subgroups in primary and metastatic sites. Mod Pathol. 2023;36(9):100245.","journal-title":"Mod Pathol"},{"issue":"1","key":"15128_CR44","doi-asserted-by":"publisher","first-page":"15369","DOI":"10.1038\/s41598-024-66463-6","volume":"14","author":"K Kojima","year":"2024","unstructured":"Kojima K, Samejima H, Iguchi T, Tokunaga T, Okishio K, Yoon H. Nonlinear association between PD-L1 expression levels and the risk of postoperative recurrence in non-small cell lung cancer. Sci Rep. 2024;14(1):15369.","journal-title":"Sci Rep"},{"key":"15128_CR45","doi-asserted-by":"publisher","first-page":"1115291","DOI":"10.3389\/fimmu.2023.1115291","volume":"14","author":"C Liu","year":"2023","unstructured":"Liu C, Zhao W, Xie J, Lin H, Hu X, Li C, et al. Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer. Front Immunol. 2023;14:1115291.","journal-title":"Front Immunol"},{"key":"15128_CR46","doi-asserted-by":"publisher","unstructured":"Jiang L, Zhang Z, Guo S, Zhao Y, Zhou P. Clinical-radiomics nomogram based on contrast-enhanced ultrasound for preoperative prediction of cervical lymph node metastasis in papillary thyroid carcinoma. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15051613.","DOI":"10.3390\/cancers15051613"},{"issue":"6","key":"15128_CR47","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1245\/s10434-015-5043-9","volume":"23","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Wang R, Shen X, Pan Y, Cheng C, Li Y, et al. Minor components of micropapillary and solid subtypes in lung adenocarcinoma are predictors of lymph node metastasis and poor prognosis. Ann Surg Oncol. 2016;23(6):2099\u2013105.","journal-title":"Ann Surg Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15128-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:03:09Z","timestamp":1762952589000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15128-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15128"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15128-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4783280\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University(Approval Number: 2024-E109-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Our research contains no personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1752"}}